Publicaciones en las que colabora con Gabriel Gastaminza Lasarte (22)

2023

  1. Reliability of a novel electro-medical device for wheal size measurement in allergy skin testing: An exploratory clinical trial

    Allergy: European Journal of Allergy and Clinical Immunology

2022

  1. Unraveling the Diagnosis of Kiwifruit Allergy: Usefulness of Current Diagnostic Tests

    Journal of Investigational Allergology and Clinical Immunology, Vol. 32, Núm. 3, pp. 206-212

  2. Validation of a commercial allergen microarray platform for specific immunoglobulin E detection of respiratory and plant food allergens

    Annals of Allergy, Asthma and Immunology, Vol. 128, Núm. 3, pp. 283-290.e4

2021

  1. Approach to occupational contact dermatitis in an industrialized region of Spain

    Journal of Investigational Allergology and Clinical Immunology

  2. Validation of novel recipes for masking peanuts in double-blind, placebo-controlled food challenges

    Annals of Allergy, Asthma and Immunology, Vol. 127, Núm. 5, pp. 575-578

2019

  1. Efficacy and Safety of Omalizumab (Xolair) for Cholinergic Urticaria in Patients Unresponsive to a Double Dose of Antihistamines: A Randomized Mixed Double-Blind and Open-Label Placebo-Controlled Clinical Trial

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 7, Núm. 5, pp. 1599-1609.e1

2017

  1. Adjuvants for allergy immunotherapeutics

    Human Vaccines and Immunotherapeutics, Vol. 13, Núm. 10, pp. 2416-2427

  2. Improvement of the elevated tryptase criterion to discriminate IgE- from non-IgE-mediated allergic reactions

    Anesthesia and Analgesia, Vol. 127, Núm. 2, pp. 414-419

  3. Induction of tolerance to different types of fish through desensitization with hake

    Pediatric Allergy and Immunology

  4. Omalizumab efficacy in cases of chronic spontaneous urticaria is not explained by the inhibition of sera activity in effector cells

    Scientific Reports, Vol. 7, Núm. 1

  5. Oral immunotherapy using polymeric nanoparticles loaded with peanut proteins in a murine model of fatal anaphylaxis

    Immunotherapy, Vol. 9, Núm. 15, pp. 1205-1217

2016

  1. Comparable actions of omalizumab on mast cells and basophils

    Clinical and Experimental Allergy, Vol. 46, Núm. 1, pp. 92-102

2015

  1. Do skin prick test and in vitro techniques diagnose sensitization to peach lipid transfer protein and profilin equally well in allergy to plant food and pollen?

    Journal of Investigational Allergology and Clinical Immunology, Vol. 25, Núm. 4, pp. 283-287

  2. Queilitis de contacto alérgica por propil-galatos y sensibilización a dentífricos

    Casos clínicos en dermatitis de contacto (Martí Tor), pp. 90-93

  3. The incidence of perioperative hypersensitivity reactions: A single-center, prospective, cohort study

    Anesthesia and Analgesia, Vol. 121, Núm. 1, pp. 117-123

2014

  1. Immunogenicity of peanut proteins containing poly(anhydride) nanoparticles

    Clinical and Vaccine Immunology, Vol. 21, Núm. 8, pp. 1106-1112

  2. Nanoparticle based-immunotherapy against allergy

    Immunotherapy, Vol. 6, Núm. 7, pp. 885-897

  3. The usefulness of plasma histamine and different tryptase cut-off points in the diagnosis of peranaesthetic hypersensitivity reactions

    Clinical and Experimental Allergy, Vol. 44, Núm. 2, pp. 270-277

2012

  1. Nanoparticles and microparticles for allergen immunotherapy

    Journal of investigational allergology & clinical immunology, Vol. 22, Núm. suppl. 1, pp. 7-15

  2. Nuevas formas farmacéuticas para el tratamiento de enfermedades alérgicas

    Anales del sistema sanitario de Navarra, Vol. 35, Núm. 1, pp. 41-51